Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 105 | 2024 | 1339 | 17.890 |
Why?
|
Sarcomeres | 43 | 2024 | 379 | 9.090 |
Why?
|
Genetic Testing | 31 | 2024 | 3595 | 2.810 |
Why?
|
Hypertrophy, Left Ventricular | 24 | 2024 | 855 | 2.800 |
Why?
|
Benzylamines | 6 | 2021 | 251 | 1.950 |
Why?
|
Uracil | 6 | 2021 | 210 | 1.780 |
Why?
|
Cardiac Myosins | 14 | 2023 | 128 | 1.570 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 7 | 2024 | 429 | 1.510 |
Why?
|
Mutation | 44 | 2024 | 30196 | 1.330 |
Why?
|
Myosin Heavy Chains | 13 | 2021 | 403 | 1.120 |
Why?
|
Ventricular Function, Left | 16 | 2023 | 3928 | 1.110 |
Why?
|
Cardiomyopathy, Dilated | 7 | 2017 | 845 | 1.110 |
Why?
|
Magnetic Resonance Imaging, Cine | 12 | 2022 | 1094 | 1.060 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2023 | 2136 | 1.020 |
Why?
|
Defibrillators, Implantable | 7 | 2021 | 1490 | 1.020 |
Why?
|
Exercise Tolerance | 6 | 2024 | 841 | 0.990 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 5 | 2012 | 63 | 0.950 |
Why?
|
Heart Failure | 18 | 2023 | 11840 | 0.920 |
Why?
|
Genetic Counseling | 6 | 2024 | 634 | 0.910 |
Why?
|
Phenotype | 33 | 2024 | 16721 | 0.870 |
Why?
|
Myocardium | 13 | 2023 | 4760 | 0.860 |
Why?
|
Death, Sudden, Cardiac | 15 | 2022 | 1568 | 0.850 |
Why?
|
Ventricular Remodeling | 10 | 2024 | 1272 | 0.840 |
Why?
|
Myocardial Contraction | 7 | 2020 | 1515 | 0.810 |
Why?
|
Genetic Predisposition to Disease | 32 | 2024 | 18071 | 0.800 |
Why?
|
Troponin T | 9 | 2023 | 785 | 0.790 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 78 | 0.790 |
Why?
|
Pedigree | 15 | 2023 | 4526 | 0.780 |
Why?
|
Carrier Proteins | 18 | 2022 | 4913 | 0.780 |
Why?
|
Echocardiography | 21 | 2021 | 5045 | 0.780 |
Why?
|
Cardiomyopathies | 10 | 2023 | 2067 | 0.760 |
Why?
|
Heart Ventricles | 11 | 2021 | 3832 | 0.680 |
Why?
|
Heterozygote | 6 | 2021 | 2794 | 0.640 |
Why?
|
Exercise Test | 3 | 2024 | 2180 | 0.620 |
Why?
|
Registries | 16 | 2024 | 8297 | 0.600 |
Why?
|
Heart | 6 | 2024 | 4414 | 0.600 |
Why?
|
Atrial Fibrillation | 8 | 2024 | 5189 | 0.590 |
Why?
|
Echocardiography, Doppler | 8 | 2016 | 899 | 0.580 |
Why?
|
Losartan | 4 | 2023 | 263 | 0.500 |
Why?
|
Humans | 143 | 2024 | 765956 | 0.470 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 851 | 0.470 |
Why?
|
Genotype | 17 | 2020 | 13024 | 0.460 |
Why?
|
Founder Effect | 2 | 2020 | 185 | 0.460 |
Why?
|
Genetic Variation | 11 | 2024 | 6610 | 0.460 |
Why?
|
Calcium Channel Blockers | 3 | 2020 | 686 | 0.460 |
Why?
|
Diltiazem | 1 | 2014 | 132 | 0.450 |
Why?
|
Cardiology | 4 | 2024 | 1702 | 0.450 |
Why?
|
Double-Blind Method | 12 | 2024 | 12437 | 0.450 |
Why?
|
Diastole | 8 | 2018 | 785 | 0.440 |
Why?
|
Adult | 66 | 2024 | 223038 | 0.430 |
Why?
|
Genetics, Medical | 3 | 2018 | 334 | 0.410 |
Why?
|
Fibrosis | 8 | 2022 | 2070 | 0.400 |
Why?
|
Young Adult | 31 | 2024 | 59886 | 0.390 |
Why?
|
American Heart Association | 3 | 2024 | 1047 | 0.390 |
Why?
|
Heart-Assist Devices | 3 | 2021 | 1296 | 0.380 |
Why?
|
Male | 84 | 2024 | 363691 | 0.380 |
Why?
|
Contrast Media | 4 | 2022 | 5329 | 0.370 |
Why?
|
Mitral Valve | 3 | 2018 | 1476 | 0.370 |
Why?
|
Adolescent | 35 | 2024 | 88832 | 0.360 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1030 | 0.360 |
Why?
|
Female | 84 | 2024 | 396101 | 0.350 |
Why?
|
Disease Progression | 13 | 2024 | 13631 | 0.350 |
Why?
|
Middle Aged | 63 | 2024 | 223004 | 0.340 |
Why?
|
Procollagen | 1 | 2010 | 189 | 0.330 |
Why?
|
Child | 25 | 2024 | 80563 | 0.330 |
Why?
|
Muscle Proteins | 5 | 2021 | 1158 | 0.320 |
Why?
|
Troponin I | 3 | 2024 | 655 | 0.310 |
Why?
|
Cost of Illness | 1 | 2018 | 1950 | 0.300 |
Why?
|
Glycogen Storage Disease Type IIb | 2 | 2023 | 18 | 0.300 |
Why?
|
Heart Diseases | 2 | 2013 | 2821 | 0.270 |
Why?
|
Electrocardiography | 7 | 2018 | 6404 | 0.270 |
Why?
|
Penetrance | 3 | 2023 | 388 | 0.270 |
Why?
|
Mutation, Missense | 6 | 2021 | 2589 | 0.270 |
Why?
|
Lamin Type A | 2 | 2017 | 186 | 0.260 |
Why?
|
Predictive Value of Tests | 13 | 2022 | 15398 | 0.250 |
Why?
|
Risk Factors | 16 | 2023 | 74836 | 0.250 |
Why?
|
Genetics | 2 | 2024 | 114 | 0.250 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2006 | 311 | 0.240 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1727 | 0.240 |
Why?
|
Peptide Fragments | 2 | 2024 | 5125 | 0.240 |
Why?
|
Patient Care | 1 | 2010 | 629 | 0.240 |
Why?
|
DNA Mutational Analysis | 6 | 2017 | 4108 | 0.240 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.240 |
Why?
|
Primary Prevention | 2 | 2021 | 1187 | 0.220 |
Why?
|
Quality of Life | 3 | 2024 | 13461 | 0.220 |
Why?
|
Arrhythmias, Cardiac | 4 | 2023 | 2247 | 0.220 |
Why?
|
Prognosis | 12 | 2023 | 29921 | 0.220 |
Why?
|
Aged | 40 | 2024 | 171114 | 0.220 |
Why?
|
Disease | 1 | 2009 | 676 | 0.220 |
Why?
|
Heart Septum | 2 | 2024 | 303 | 0.210 |
Why?
|
Child, Preschool | 13 | 2022 | 42500 | 0.210 |
Why?
|
Sex Characteristics | 4 | 2022 | 2643 | 0.200 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 15651 | 0.200 |
Why?
|
Hypertrophy | 2 | 2022 | 559 | 0.200 |
Why?
|
Stroke Volume | 6 | 2023 | 5596 | 0.190 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2022 | 61 | 0.190 |
Why?
|
Databases, Genetic | 2 | 2021 | 1751 | 0.190 |
Why?
|
Risk Assessment | 10 | 2022 | 24283 | 0.190 |
Why?
|
Tropomyosin | 3 | 2013 | 103 | 0.190 |
Why?
|
Heart Arrest | 2 | 2023 | 1516 | 0.190 |
Why?
|
Asymptomatic Diseases | 3 | 2020 | 586 | 0.180 |
Why?
|
Point Mutation | 2 | 2010 | 1590 | 0.180 |
Why?
|
Family | 4 | 2024 | 3209 | 0.180 |
Why?
|
Genomics | 4 | 2024 | 5929 | 0.180 |
Why?
|
Recovery of Function | 3 | 2020 | 2966 | 0.180 |
Why?
|
Genome, Human | 3 | 2021 | 4448 | 0.170 |
Why?
|
Genes, Dominant | 3 | 2013 | 856 | 0.170 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2020 | 262 | 0.170 |
Why?
|
Denmark | 2 | 2019 | 774 | 0.170 |
Why?
|
Early Diagnosis | 2 | 2018 | 1187 | 0.160 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 4 | 2023 | 53 | 0.160 |
Why?
|
Twins, Monozygotic | 1 | 2021 | 469 | 0.160 |
Why?
|
Genetic Markers | 4 | 2015 | 2601 | 0.160 |
Why?
|
Systole | 3 | 2018 | 935 | 0.150 |
Why?
|
Cardiac Imaging Techniques | 2 | 2018 | 280 | 0.150 |
Why?
|
Muscle Relaxation | 2 | 2020 | 138 | 0.150 |
Why?
|
Online Systems | 1 | 2019 | 181 | 0.150 |
Why?
|
Mortality | 2 | 2020 | 2904 | 0.150 |
Why?
|
Heart Atria | 3 | 2021 | 1363 | 0.150 |
Why?
|
Age Factors | 5 | 2020 | 18380 | 0.150 |
Why?
|
Mass Screening | 4 | 2019 | 5445 | 0.150 |
Why?
|
Papillary Muscles | 1 | 2018 | 192 | 0.150 |
Why?
|
Myofibrils | 2 | 2020 | 143 | 0.140 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.140 |
Why?
|
Hospitals, Special | 1 | 2017 | 88 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36532 | 0.140 |
Why?
|
Myocytes, Cardiac | 3 | 2020 | 1668 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2024 | 841 | 0.130 |
Why?
|
Atrial Function, Left | 1 | 2017 | 189 | 0.130 |
Why?
|
Time Factors | 8 | 2024 | 40065 | 0.130 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2014 | 252 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1736 | 0.130 |
Why?
|
Patient Selection | 2 | 2018 | 4255 | 0.130 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 878 | 0.130 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.130 |
Why?
|
Blood Platelet Disorders | 1 | 1996 | 59 | 0.130 |
Why?
|
Homozygote | 1 | 2000 | 1775 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2022 | 326 | 0.120 |
Why?
|
Brazil | 1 | 2019 | 1248 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2024 | 65189 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1731 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2022 | 81515 | 0.120 |
Why?
|
Cardiac Volume | 1 | 2015 | 196 | 0.120 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 26313 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2119 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.110 |
Why?
|
Arterio-Arterial Fistula | 1 | 2013 | 20 | 0.110 |
Why?
|
Communication | 2 | 2018 | 3916 | 0.110 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1996 | 248 | 0.110 |
Why?
|
Collagen | 2 | 2013 | 2618 | 0.110 |
Why?
|
Professional-Family Relations | 1 | 2017 | 501 | 0.110 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 4247 | 0.110 |
Why?
|
Cohort Studies | 8 | 2023 | 41647 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 1996 | 696 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1167 | 0.100 |
Why?
|
Health Education | 1 | 2019 | 1060 | 0.100 |
Why?
|
Alleles | 2 | 2017 | 6897 | 0.100 |
Why?
|
Lod Score | 2 | 2006 | 598 | 0.090 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4772 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2024 | 39194 | 0.090 |
Why?
|
Catheter Ablation | 2 | 2021 | 2788 | 0.090 |
Why?
|
Hemodynamics | 3 | 2020 | 4183 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3910 | 0.090 |
Why?
|
Heart Function Tests | 2 | 2014 | 317 | 0.090 |
Why?
|
Incidence | 5 | 2022 | 21480 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1454 | 0.090 |
Why?
|
Pilot Projects | 4 | 2019 | 8733 | 0.090 |
Why?
|
United States | 11 | 2024 | 72898 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2021 | 22222 | 0.080 |
Why?
|
alpha-Galactosidase | 1 | 2010 | 59 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2013 | 823 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2022 | 3584 | 0.080 |
Why?
|
Ventricular Myosins | 1 | 2009 | 65 | 0.080 |
Why?
|
Amino Acid Substitution | 2 | 2006 | 1740 | 0.080 |
Why?
|
Muscle Cells | 1 | 2010 | 194 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1142 | 0.080 |
Why?
|
Fabry Disease | 1 | 2010 | 90 | 0.080 |
Why?
|
Logistic Models | 3 | 2014 | 13266 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12795 | 0.080 |
Why?
|
Therapeutics | 1 | 2009 | 113 | 0.080 |
Why?
|
Animals | 9 | 2022 | 168759 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1253 | 0.080 |
Why?
|
Policy Making | 1 | 2012 | 546 | 0.080 |
Why?
|
Myosins | 1 | 2010 | 408 | 0.070 |
Why?
|
Medical History Taking | 1 | 2012 | 777 | 0.070 |
Why?
|
Health Status | 1 | 2021 | 4080 | 0.070 |
Why?
|
Primary Health Care | 2 | 2015 | 4736 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2020 | 1237 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3708 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3819 | 0.070 |
Why?
|
Disease Management | 3 | 2024 | 2535 | 0.070 |
Why?
|
Actins | 1 | 2014 | 2056 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2517 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10383 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3785 | 0.070 |
Why?
|
Collagen Type I | 1 | 2010 | 615 | 0.070 |
Why?
|
Blood Volume | 1 | 2008 | 542 | 0.070 |
Why?
|
Research | 1 | 2015 | 1975 | 0.070 |
Why?
|
Troponin | 1 | 2010 | 533 | 0.060 |
Why?
|
Models, Molecular | 1 | 2016 | 5379 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12509 | 0.060 |
Why?
|
Infant | 5 | 2022 | 36385 | 0.060 |
Why?
|
Societies, Medical | 1 | 2018 | 3956 | 0.060 |
Why?
|
Haplotypes | 2 | 2006 | 2728 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5089 | 0.060 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 184 | 0.060 |
Why?
|
Contractile Proteins | 1 | 2006 | 240 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18294 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1611 | 0.060 |
Why?
|
Codon | 1 | 2006 | 595 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6203 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8927 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 15839 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7425 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2015 | 2736 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2024 | 198 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 663 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 595 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8067 | 0.050 |
Why?
|
Computational Biology | 1 | 2015 | 3559 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2006 | 735 | 0.050 |
Why?
|
Energy Metabolism | 2 | 2020 | 2892 | 0.050 |
Why?
|
Motion | 1 | 2006 | 781 | 0.050 |
Why?
|
Aneurysm, False | 1 | 2005 | 264 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6919 | 0.050 |
Why?
|
Coronary Circulation | 1 | 2008 | 1602 | 0.050 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2005 | 477 | 0.050 |
Why?
|
Long QT Syndrome | 1 | 2006 | 474 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3358 | 0.050 |
Why?
|
Heart Transplantation | 4 | 2020 | 3310 | 0.050 |
Why?
|
Ion Channels | 1 | 2006 | 1045 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 54806 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16047 | 0.050 |
Why?
|
Mice | 4 | 2022 | 81818 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4203 | 0.040 |
Why?
|
Calcium | 2 | 2013 | 5767 | 0.040 |
Why?
|
Iceland | 1 | 2020 | 183 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3458 | 0.040 |
Why?
|
DNA | 2 | 2010 | 7202 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3343 | 0.040 |
Why?
|
Algorithms | 4 | 2020 | 14071 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4331 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 6208 | 0.040 |
Why?
|
Base Sequence | 1 | 2009 | 12403 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4618 | 0.040 |
Why?
|
Gadolinium | 1 | 2022 | 965 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 13075 | 0.040 |
Why?
|
Endocardium | 1 | 2018 | 249 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 786 | 0.030 |
Why?
|
Victoria | 1 | 2016 | 64 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14652 | 0.030 |
Why?
|
Capillaries | 1 | 2020 | 755 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 431 | 0.030 |
Why?
|
Virulence | 1 | 2020 | 1289 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1061 | 0.030 |
Why?
|
Electric Countershock | 1 | 2020 | 534 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 225 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1638 | 0.030 |
Why?
|
Health Communication | 1 | 2019 | 216 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 317 | 0.030 |
Why?
|
Curriculum | 2 | 2024 | 3782 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20125 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2020 | 837 | 0.030 |
Why?
|
France | 1 | 2016 | 495 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3529 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1995 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15880 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1007 | 0.030 |
Why?
|
Singapore | 1 | 2015 | 297 | 0.030 |
Why?
|
London | 1 | 2014 | 233 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1870 | 0.030 |
Why?
|
Pericardium | 1 | 2018 | 679 | 0.030 |
Why?
|
Tachycardia, Ventricular | 1 | 2002 | 1310 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 6546 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3202 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3432 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2016 | 589 | 0.030 |
Why?
|
Incidental Findings | 1 | 2018 | 697 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2005 | 11501 | 0.030 |
Why?
|
Isometric Contraction | 1 | 2013 | 149 | 0.030 |
Why?
|
Italy | 1 | 2014 | 854 | 0.030 |
Why?
|
Phobic Disorders | 1 | 2015 | 440 | 0.030 |
Why?
|
Anti-Anxiety Agents | 1 | 2015 | 402 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12807 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59488 | 0.020 |
Why?
|
Protein Conformation | 1 | 2020 | 3946 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2014 | 533 | 0.020 |
Why?
|
Panic Disorder | 1 | 2015 | 610 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.020 |
Why?
|
Inservice Training | 1 | 2014 | 375 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 605 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3051 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 484 | 0.020 |
Why?
|
Oncogenes | 1 | 1996 | 1235 | 0.020 |
Why?
|
Blood Pressure | 2 | 2021 | 8532 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1749 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1996 | 1789 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1668 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 830 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2023 | 12976 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1883 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 682 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 1999 | 0.020 |
Why?
|
Stroke | 2 | 2020 | 9747 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1495 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2208 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1426 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10602 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5937 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3796 | 0.020 |
Why?
|
Psychotherapy | 1 | 2015 | 1645 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9591 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4850 | 0.020 |
Why?
|
Acute Disease | 1 | 1996 | 7232 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3229 | 0.020 |
Why?
|
Autopsy | 1 | 2009 | 1011 | 0.020 |
Why?
|
Atherectomy | 1 | 2005 | 47 | 0.010 |
Why?
|
History, 20th Century | 1 | 2013 | 2761 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2020 | 4300 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1588 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18973 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3685 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3655 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20660 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9649 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5506 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8278 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13039 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2971 | 0.010 |
Why?
|
Pregnancy | 2 | 2015 | 30258 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3481 | 0.010 |
Why?
|
Medical Records | 1 | 2005 | 1409 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3925 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1217 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4058 | 0.010 |
Why?
|
Treatment Failure | 1 | 2005 | 2652 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4863 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4627 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5302 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11888 | 0.010 |
Why?
|
Stents | 1 | 2005 | 3213 | 0.010 |
Why?
|
Coronary Disease | 1 | 2005 | 5912 | 0.010 |
Why?
|
Internship and Residency | 1 | 2008 | 5946 | 0.000 |
Why?
|